India’s health in 2025 has been shaped by rising diseases, fragile systems, and mounting environmental risks. From funding shortfalls and weak health programmes to drug safety lapses and pollution-driven illness, these challenges are deeply interconnected.
Ozempic, Mounjaro and weight loss: What GLP-1 drugs mean for body positivity
As drugs like Ozempic, Mounjaro and Wegovy gain traction in India, they are reframing obesity as a chronic medical condition...





